Guangdong Biolight Meditech Co., Ltd. (SHE:300246)

Market Cap	3.46B +110.3%
Revenue (ttm)	1.05B -0.3%
Net Income	-66.14M
EPS	-0.25
Shares Out	261.61M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.10 (0.76%)
Ex-Dividend Date	Nov 26, 2025

Volume	7,047,101
Average Volume	17,642,131
Open	13.42
Previous Close	13.42
Day's Range	13.21 - 13.60
52-Week Range	5.43 - 14.98
Beta	0.79
RSI	57.08
Earnings Date	Apr 25, 2026

About SHE:300246

Guangdong Biolight Meditech Co., Ltd. engages in the research and development, production, sale, and service of medical devices products and solutions in China. It operates in two segments, Life Information and Support, and Kidney Disease. The company offers emergency and critical care monitor, subcritical care monitor, general ward monitor, outpatient monitor, neonatal monitor, infusion pump, electrocardiograph, maternal and fetal monitor, defibrillator, multifunctional suspension device, internet of things, and central station; hemodiafiltrat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Employees: 1,335
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300246

Financial Performance

In 2024, SHE:300246's revenue was 1.06 billion, a decrease of -11.18% compared to the previous year's 1.19 billion. Losses were -71.44 million, 9.60% more than in 2023.